⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

INCY

Incyte Corporation

Healthcare · Biotechnology

115.71USD

-1.2200 (-1.04%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on INCY.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 115.71
P/E16.4
Dvd Ind Yld0.0%
P/B4.17
P/S4.4
Curr EV/T12M EBITDA11.1
Mkt Cap (USD)23.5B
Curr EV (USD)19.0B
2)

Per Share Data

EPS T12M7.11
DPS—
Bk Val Per Sh31.57
Rev/Sh25.92
Cash/Sh22.38
Curr Shares Out202.7M
FCF/Sh4.31
3)

Cash Flow Analysis

P/CF15.5
Curr P/FCF26.3
CF/NI1.1
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales28.3%
Eff Interest Rate0.0%
4)

Growth Potential

Dil EPS 1Y Gr4173.3%
Cap 1Y Gr49.9%
BPS 1Y Gr57.2%
R&D To Sales39.7%
Retention Rate100.0%
Rev 1Y Gr21.2%
FCF 1Y Gr56.9%
Assets 1Y Gr27.8%
5)

Profitability

EBITDA1.7B
EBIT1.6B
Operating Margin30.0%
Pretax Margin33.1%
Net Margin26.7%
ROA21.9%
ROE30.8%
ROC5.3%
Asset Turnover0.82
6)

Structure

Current Ratio3.68
Quick Ratio4.31
Debt/Assets259.0%
Debt/Com Eq338.1%
Net Debt/EBITDA9.12
Tot Debt/Capital77.2%
Gross Margin92.5%
EBIT/Int Exp689.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.